Kara Renita Mcmillian

Array ( [id] => 18215216 [patent_doc_number] => 11590129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Combination therapy with an antitumor alkaloid [patent_app_type] => utility [patent_app_number] => 15/824551 [patent_app_country] => US [patent_app_date] => 2017-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 296 [patent_no_of_words] => 25694 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12259354 [patent_doc_number] => 20180078550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID' [patent_app_type] => utility [patent_app_number] => 15/824506 [patent_app_country] => US [patent_app_date] => 2017-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 28710 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15408681 [patent_doc_number] => 20200024662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => METHODS FOR TREATING OPIOID ADDICTION [patent_app_type] => utility [patent_app_number] => 16/463347 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15175293 [patent_doc_number] => 20190358238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-28 [patent_title] => ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES [patent_app_type] => utility [patent_app_number] => 16/461716 [patent_app_country] => US [patent_app_date] => 2017-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15035381 [patent_doc_number] => 20190328695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => ORAL COMPOSITION WITH IMMUNOMODULATING EFFECT ON NATURAL KILLER CELLS [patent_app_type] => utility [patent_app_number] => 16/347648 [patent_app_country] => US [patent_app_date] => 2017-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14774825 [patent_doc_number] => 20190262310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => THERAPY OF POST-OPERATIVE EMESIS WITH AMISULPRIDE [patent_app_type] => utility [patent_app_number] => 16/346563 [patent_app_country] => US [patent_app_date] => 2017-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14774851 [patent_doc_number] => 20190262323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS [patent_app_type] => utility [patent_app_number] => 16/345995 [patent_app_country] => US [patent_app_date] => 2017-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12675979 [patent_doc_number] => 20180117159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => Method for producing solid formulations with improved dissolution by annealing with an adjuvant [patent_app_type] => utility [patent_app_number] => 15/732352 [patent_app_country] => US [patent_app_date] => 2017-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15732352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14806035 [patent_doc_number] => 20190269627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => MEMANTINE COMBINATIONS AND USE [patent_app_type] => utility [patent_app_number] => 16/345329 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12603015 [patent_doc_number] => 20180092835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 15/727772 [patent_app_country] => US [patent_app_date] => 2017-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14712625 [patent_doc_number] => 20190247376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST ATTENUATES ILC2-DEPENDENT AIRWAY HYPERREACTIVITY [patent_app_type] => utility [patent_app_number] => 16/336879 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15342387 [patent_doc_number] => 20200009085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => Methods For Treating Ovarian Cancer [patent_app_type] => utility [patent_app_number] => 16/336358 [patent_app_country] => US [patent_app_date] => 2017-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12786034 [patent_doc_number] => 20180153847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => TREPROSTINIL PRODRUGS [patent_app_type] => utility [patent_app_number] => 15/716007 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15716007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15360803 [patent_doc_number] => 20200016166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => DRUG-INDUCED EPIGENETIC REMODELING TO PREVENT FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/335716 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15432153 [patent_doc_number] => 20200030259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => Antiestrogens and/or Aromatase Inhibitors for Use in Treating Obesity and Related Symptoms [patent_app_type] => utility [patent_app_number] => 16/335693 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14649329 [patent_doc_number] => 20190231793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => USE OF HARRINGTONINES IN THE TREATMENT OF BREAST CANCER, IN PARTICULAR TRIPLE-NEGATIVE BREAST CANCER [patent_app_type] => utility [patent_app_number] => 16/335747 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12125017 [patent_doc_number] => 20180008602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID' [patent_app_type] => utility [patent_app_number] => 15/711478 [patent_app_country] => US [patent_app_date] => 2017-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 28708 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15711478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12580590 [patent_doc_number] => 20180085359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => USE OF CHELATORS OF DIVALENT CATIONS TO PROMOTE NERVE REGENERATION [patent_app_type] => utility [patent_app_number] => 15/710436 [patent_app_country] => US [patent_app_date] => 2017-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12124971 [patent_doc_number] => 20180008557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'USE OF TWO BOTANICALS WITH COMPLEMENTARY ACTIVITIES FOR IMPROVEMENT OF SKIN' [patent_app_type] => utility [patent_app_number] => 15/710194 [patent_app_country] => US [patent_app_date] => 2017-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11663 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14482589 [patent_doc_number] => 10328053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Substituted pyrrolizine compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/686499 [patent_app_country] => US [patent_app_date] => 2017-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50982 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15686499 [rel_patent_id] =>[rel_patent_doc_number] =>)